Phase I Trial of Etoposide, Carboplatin, and GM-CSF in Extensive Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Phase I Trial of Etoposide, Carboplatin, and GM-CSF in Extensive Small-Cell Lung Cancer

Published:1997-02 Issue:1 Volume:20 Page:24-30
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:American Journal of Clinical Oncology

Author:

Luikart Sharon D.,Herndon James E.,Hollis Donna R.,MacDonald Margaret,Maurer L. Herbert,Crawford Jeffrey,Clamon Gerald H.,Wright Jonathan,Perry Michael C.,Ozer Howard,Green Mark R.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference28 articles.

1. Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first-line combination therapy for small-cell lung cancer.

2. Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer.

3. VP-16 and carboplatin in previously untreated patients with extensive small cell lung cancer: a study of the National Cancer Institute of Canada Clinical Trials Group

4. Phase I/II Trial of Etoposide and Carboplatin in Extensive Small-Cell Lung Cancer

5. Hemopoietic Growth Factors: A Review

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Cancer and Leukemia Group B Respiratory Committee;Clinical Cancer Research;2006-06-01

2. Carboplatin and Etoposide (CE) Regimen;Hospital Pharmacy;2000-02

3. Growth stimulation of non-small cell lung cancer xenografts by granulocyte-macrophage colony-stimulating factor (GM-CSF);European Journal of Cancer;1998-11

4. Carboplatin in the Treatment of Small Cell Lung Cancer;The Oncologist;1998-06